Put companies on watchlist
DKSH Management Ltd.
ISIN: CH0126673539
WKN: A1JU9U
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

DKSH Management Ltd. · ISIN: CH0126673539 · EQS - Company News (54 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 1383845
27 June 2022 07:00AM

DKSH Performance Materials Strengthens its Life Sciences Capabilities by Acquiring Refarmed Group


DKSH Management Ltd. / Key word(s): Acquisition/Mergers & Acquisitions
DKSH Performance Materials Strengthens its Life Sciences Capabilities by Acquiring Refarmed Group

27.06.2022 / 07:00


Media release

DKSH has announced the acquisition of Swiss Refarmed Group today. With this transaction, DKSH Performance Materials significantly expands its capabilities in Active Pharmaceutical Ingredients (APIs) and strengthens its position as a leading Life Sciences distributor.

Zurich, Switzerland, June 27, 2022 – Through the acquisition of Refarmed Group, DKSH Performance Materials obtains a uniquely positioned business which provides value-added products and services for customers in the pharma industry across Europe, Asia Pacific, and the Americas.

Refarmed Group provides Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) for generic drug manufacturers. This includes the sourcing of the ingredients as well as providing technical and regulatory support. Headquartered in Switzerland, Refarmed’s team of pharmaceutical experts serves approximately 300 customers across Europe, Asia, and the Americas. 

Refarmed generates net sales of over CHF 60 million at sound profitability and return on capital. DKSH will acquire the business and will fully integrate the company into its existing operations.

Dr. Giuseppe Nonni, President at Refarmed, commented: "We have successfully serviced our customers for almost 40 years. In DKSH, we have found an experienced and trusted partner and we look forward to leveraging our expertise through their international reach and market expertise."

Thomas Sul and Natale Capri, Co-Heads Business Unit Performance Materials at DKSH, jointly added: “We are excited to strengthen our capabilities in Life Sciences by teaming up with a trusted player with strong expertise. Refarmed’s products and services complement our existing portfolio and increases our access Pharma industries. We welcome all Refarmed employees and look forward to continuing to grow the business together with them.”

About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution, and logistics as well as after-sales services. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 33,100 specialists, generating net sales of CHF 11.1 billion in 2021. The DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care, and various industrial applications. With 48 innovation centers and regulatory support worldwide, we create cutting-edge formulations that comply with local regulations. With around 1,370 specialists, the Business Unit generated net sales of CHF 1.3 billion in 2021. www.dksh.com/pm

For more information please contact:

DKSH Holding Ltd.

Rafael Duarte
Director, Group Investor Relations
Phone +41 44 386 7318
rafael.duarte@dksh.com

Demet Biçer
Manager, Group Media Relations
Phone +41 44 386 7117
demet.bicer@dksh.com

Till Leisner
Head, Group Investor & Media Relations, Sustainability
Phone +41 44 386 7315
till.leisner@dksh.com



End of Media Release


Language: English
Company: DKSH Management Ltd.
Wiesenstrasse 8
8008 Zurich
Switzerland
Phone: 044 386 72 72
E-mail: media@dksh.com
Internet: www.dksh.com
ISIN: CH0126673539
Valor: 12667353
Listed: SIX Swiss Exchange
EQS News ID: 1383845

 
End of News EQS News Service

1383845  27.06.2022 

fncls.ssp?fn=show_t_gif&application_id=1383845&application_name=news&site_id=boersengefluester_html
Visual performance / price development - DKSH Management Ltd.
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.